Frequently Asked Questions about the ECOG Clinical trial for
People with Stage II or III Rectal Cancer (E5204)
Follow the link below to view the handout answering frequently asked
questions about the E5204 ECOG Clinical Trial for Patients with stage
II or III rectal cancer. This is an "Intergroup Randomized Phase III
Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs
Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients
with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation".
The document is in Adobe Acrobat format. If you do not already
have Adobe Acrobat Reader running on your computer you can
download this software free of charge from the Adobe web site.
How to contact ECOG
All contents copyright © 2001 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: February 27, 2007
